BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 954664)

  • 1. Influence of synthetic somatostatin upon growth hormone release from perifused rat pituitaries.
    Stachura ME
    Endocrinology; 1976 Sep; 99(3):678-83. PubMed ID: 954664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.
    Stachura ME; Tyler JM; Farmer PK
    Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone release: interaction of increased extracellular calcium and somatostatin.
    Stachura ME
    Endocr Res; 1986; 12(1):69-92. PubMed ID: 2870919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal and dibutyryl cyclic AMP-stimulated release of newly synthesized and stored growth hormone from perifused rat pituitaries.
    Stachura ME
    Endocrinology; 1976 Mar; 98(3):580-9. PubMed ID: 177264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin rapidly restores rat growth hormone (GH) release response attenuated by prior exposure to human GH-releasing factor in vitro.
    Soya H; Suzuki M
    Endocrinology; 1988 Jun; 122(6):2492-8. PubMed ID: 2897284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells.
    Fukata J; Diamond DJ; Martin JB
    Endocrinology; 1985 Aug; 117(2):457-67. PubMed ID: 2862007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of withdrawal of somatostatin and growth hormone (GH)-releasing factor on GH release in vitro.
    Kraicer J; Sheppard MS; Luke J; Lussier B; Moor BC; Cowan JS
    Endocrinology; 1988 May; 122(5):1810-5. PubMed ID: 2896117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractional reduction of somatostatin concentration interacted with rat growth hormone releasing hormone to titrate the magnitude of pulsatile growth hormone and prolactin release in perifusion.
    Stachura ME; Tyler JM; Farmer PK
    Neuroendocrinology; 1988 Nov; 48(5):500-6. PubMed ID: 2907614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural correlates of stimulated and inhibited secretion: electron microscopic observations of somatotrophs in perifused rat pituitary.
    Stachura ME; Costoff A; Tyler JM
    Neuroendocrinology; 1986; 42(5):383-91. PubMed ID: 2871502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human growth hormone (GH)-releasing factor stimulates and somatostatin inhibits the release of rat GH variants.
    Yokoya S; Friesen HG
    Endocrinology; 1986 Nov; 119(5):2097-105. PubMed ID: 2876884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological role of growth hormone (GH)-releasing factor and somatostatin in the dynamics of GH secretion in adult male rat.
    Sato M; Takahara J; Fujioka Y; Niimi M; Irino S
    Endocrinology; 1988 Oct; 123(4):1928-33. PubMed ID: 2901340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of age on somatostatin suppression of basal, growth hormone (GH)-releasing factor-stimulated, and dibutyryl adenosine 3',5'-monophosphate-stimulated GH release from rat pituitary cells in monolayer culture.
    Cuttler L; Welsh JB; Szabo M
    Endocrinology; 1986 Jul; 119(1):152-8. PubMed ID: 2873023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of stored, pre-labeled growth hormone and prolactin from perifused rat pituitary: effect of human pancreatic growth hormone-releasing factor-44.
    Stachura ME; Tyler JM; Kent PG; Farmer PK
    Endocr Res; 1986; 12(2):171-91. PubMed ID: 3015581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postsomatostatin hypersecretion of growth hormone from perifused rat anterior pituitary cells is dependent on calcium influx.
    McFarlane MB; Bruhn TO; Jackson IM
    Neuroendocrinology; 1993 Mar; 57(3):496-502. PubMed ID: 8100619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
    Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
    Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired suppression of growth hormone release by somatostatin in cultured adenohypophyseal cells of spontaneously diabetic BB/W rats.
    Welsh JB; Szabo M
    Endocrinology; 1988 Nov; 123(5):2230-4. PubMed ID: 2901949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical enhancement of pituitary growth hormone (GH) responsiveness to GH-releasing factor in the face of high somatostatin tone.
    Tannenbaum GS; Painson JC; Lengyel AM; Brazeau P
    Endocrinology; 1989 Mar; 124(3):1380-8. PubMed ID: 2563683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone-releasing factor-44 specificity for components of somatotroph and lactotroph immediate release pool substructures.
    Stachura ME; Tyler JM
    Endocrinology; 1987 May; 120(5):1719-26. PubMed ID: 3032568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of insulin-like growth factors on adult male rat pituitary function in tissue culture.
    Goodyer CG; De Stephano L; Guyda HJ; Posner BI
    Endocrinology; 1984 Oct; 115(4):1568-76. PubMed ID: 6148234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
    Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
    Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.